Intellia Therapeutics Inc. Share Price Today: Live Updates & Key Insights
Intellia Therapeutics Inc. share price today is $13, up -2.36%. The stock opened at $13.05 against the previous close of $13.15, with an intraday high of $13.57 and low of $12.81.
Intellia Therapeutics Inc. Share Price Chart
Intellia Therapeutics Inc.
Intellia Therapeutics Inc. Share Price Performance
Intellia Therapeutics Inc. Institutional Holdings
Intellia Therapeutics Inc. Market Status
Intellia Therapeutics Inc. Fundamentals
Market Cap 1516.83 M
PB Ratio 2.261
PE Ratio 0.0
Enterprise Value 1161.46 M
Total Assets 842.13 M
Volume 5219356
Intellia Therapeutics Inc. Company Financials
About Intellia Therapeutics Inc. & investment objective
Company Information Intellia Therapeutics, Inc., a clinical-stage gene editing company, focuses on the development of curative genome editing treatments. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 that is in Phase 1/2 study for the treatment of hereditary angioedema. The company has license and collaboration agreement with AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of various of B cell-mediated autoimmune diseases; ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer; and ReCode Therapeutics, Inc. to develop novel genomic medicines for the treatment of cystic fibrosis. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Organisation Biotechnology
Employees 377
Industry Biotechnology
CEO Dr. John M. Leonard M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Intellia Therapeutics Inc. FAQs
What is the share price of Intellia Therapeutics Inc. today?
The current share price of Intellia Therapeutics Inc. is $13.
Can I buy Intellia Therapeutics Inc. shares in India?
Yes, Indian investors can buy Intellia Therapeutics Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Intellia Therapeutics Inc. shares in India?
You can easily invest in Intellia Therapeutics Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Intellia Therapeutics Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Intellia Therapeutics Inc..
Can I buy fractional shares of Intellia Therapeutics Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Intellia Therapeutics Inc.?
Intellia Therapeutics Inc. has a market cap of $1516.83 M.
In which sector does Intellia Therapeutics Inc. belong?
Intellia Therapeutics Inc. operates in the Biotechnology sector.
What documents are required to invest in Intellia Therapeutics Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Intellia Therapeutics Inc.?
The PE ratio of Intellia Therapeutics Inc. is N/A and the PB ratio is 2.26.